Leading The Way: Adult ADHD Guidelines
The First Guidelines for the Clinical Diagnosis and Treatment of Adult ADHD in the United States
The recent surge in adults seeking care for ADHD, coupled with a steady increase in ADHD medication prescriptions, has underscored the pressing need for diagnostic and treatment guidelines.
Healthcare providers are not taught how to diagnose and treat ADHD in adults. The absence of clinical practice guidelines for adults has created a significant gap in mental healthcare across the country.
To address this issue, CHADD has partnered with the American Professional Society for ADHD and Related Disorders (APSARD) to develop and distribute guidelines in 2025. APSARD is leading the charge in developing the guidelines for review. CHADD is taking the lead in developing resources and toolkits for healthcare providers across the United States to implement the new diagnostic and treatment guidelines.
ADULT ADHD GUIDELINES DEVELOPMENT
The Importance of Adult ADHD Guidelines
Dr. Peter Jensen, founder of The REACH Institute, is the director of a coalition of organizations that are developing adult ADHD diagnosis and treatment guidelines for use in the United States, a joint effort of CHADD and APSARD.
For more information on the development of adult guidelines, read The Quest for Clinical Practice Guidelines for ADHD in Adults.
RESOURCES
PROJECT UPDATES
Leading the Way The First Guidelines for the Clinical Diagnosis and Treatment of Adult ADHD in the United States Healthcare providers in the United States are not taught how to diagnose and treat ADHD in adults. The absence of clinical practice guidelines for adults has created a significant gap in mental healthcare across the country.…
Featuring Dr. Peter Jensen, MD Download Slides Dr. Peter Jensen, founder of the REACH Institute, is the director of a coalition of organizations that are developing adult ADHD diagnosis and treatment guidelines for use in the United States, a joint effort of CHADD and APSARD. For more information on the development of adult guidelines, read…
Featuring Max Wiznitzer, MD, Co-chair of CHADD’s Professional Advisory Board Download PDF Learn more about ADHD before the lunch and learn: About ADHD – Overview The Science of ADHD Diagnosing ADHD Treatment of ADHD Frequently Asked Questions Have questions? Email the public policy co-chairs at PublicPolicyLiaison@CHADD.org. The CHADD Public Policy Lunch and Learn is…
In 2022, CHADD received funds from a generous donor to sponsor and support the development of national guidelines in the U.S. for the diagnosis and treatment of adult ADHD. This milestone has been achieved due to the sustained efforts of our Public Policy Committee and builds on the committee’s published recommendations emerging from a national…
CHADD and Russell A. Barkley, Ph.D., Partner Announce New Findings Lanham, Md. (Jan. 8, 2019)— The message is clear. Treatment for attention-deficit/hyperactivity disorder (ADHD), along with the related health risks it poses, has the possibility of adding an average of nine to 13 years to the lifespan of children and adults diagnosed with ADHD. This…